Postdoctoral Researcher
Roman Khadka, as part of Center for Cellular Immunotherapy (CCI), our research in the Bhoj lab is focused on cellular immunotherapy targeted against pathogenic B cells to treat autoimmune disorders. We are currently investigating efficacy and feasibility of chimeric auto-antigen receptors (CAAR) T cells in the context of Thrombotic Thrombocytopenic Purpura (TTP). In collaboration Naji lab, we are actively expanding our interests in transplantation and other autoimmune disorders including diabetes.
Stay informed and at the forefront of groundbreaking discoveries by subscribing to our newsletter, your essential source for the latest research updates from the Colton Center for Autoimmunity Consortium.